Literature DB >> 29251978

Customized recommendations and reminder text messages for automated, computer-based treatment during methadone.

Brent A Moore1, Frank D Buono1, Destiny M B Printz1, Daniel P Lloyd1, David A Fiellin2, Christopher J Cutter2, Richard S Schottenfeld1, Declan T Barry1.   

Abstract

The Recovery Line is an automated, computer-based intervention based on cognitive behavioral therapy (CBT) designed to provide real-time assistance by phone for patients in methadone maintenance. Preliminary efficacy findings were promising, however, as with other computer-based systems for substance use disorder, patient system use was less than recommended. Development and evaluation of system functions to increase patient engagement and use is needed. Thus, we conducted two randomized trials to evaluate system functions designed to increase patient use of the Recovery Line among methadone-maintained patients with continued illicit drug use. In Trial 1 (n = 60), patients received customized, system use recommendations or no recommendations on each Recovery Line call. Ratings of system usability were higher for customized recommendations (CR), but number of calls and total call time did not differ by condition. Trial 2 evaluated characteristics of reminder messages (message frame and reminder latency). Participants (N = 67) received gain- and loss-frame reminder messages, and were randomly assigned to immediate, short, or long term message latency. Although message framing had no effect, gender interacted with latency condition such that females did not differ by message latency, while males had significantly greater total contact time in the short latency conditions. Number of calls differed by condition over time such that the shorter latencies led to greater calls initially, but dissipated over time. Overall the study indicates that computer-based self-management systems can be adapted to increase patient engagement and use. (PsycINFO Database Record (c) 2017 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29251978      PMCID: PMC5737744          DOI: 10.1037/pha0000149

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  51 in total

Review 1.  Efficacy, cost-effectiveness and acceptability of self-help interventions for anxiety disorders: systematic review.

Authors:  Catrin Lewis; Jennifer Pearce; Jonathan I Bisson
Journal:  Br J Psychiatry       Date:  2012-01       Impact factor: 9.319

2.  Methods for testing theory and evaluating impact in randomized field trials: intent-to-treat analyses for integrating the perspectives of person, place, and time.

Authors:  C Hendricks Brown; Wei Wang; Sheppard G Kellam; Bengt O Muthén; Hanno Petras; Peter Toyinbo; Jeanne Poduska; Nicholas Ialongo; Peter A Wyman; Patricia Chamberlain; Zili Sloboda; David P MacKinnon; Amy Windham
Journal:  Drug Alcohol Depend       Date:  2008-01-22       Impact factor: 4.492

3.  Computerized recovery support for substance use disorders: predictors of posttreatment usage.

Authors:  Audrey A Klein
Journal:  Telemed J E Health       Date:  2014-03-11       Impact factor: 3.536

4.  Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use.

Authors:  Sean M Robinson; Linda Carter Sobell; Mark B Sobell; Gloria I Leo
Journal:  Psychol Addict Behav       Date:  2012-12-31

5.  Factors affecting cognitive function of opiate-dependent patients.

Authors:  Sabine Loeber; Helmut Nakovics; Anja Kniest; Falk Kiefer; Karl Mann; Bernhard Croissant
Journal:  Drug Alcohol Depend       Date:  2011-07-28       Impact factor: 4.492

6.  Efficacy of automated telephone continuing care following outpatient therapy for alcohol dependence.

Authors:  Gail L Rose; Joan M Skelly; Gary J Badger; Tonya A Ferraro; John E Helzer
Journal:  Addict Behav       Date:  2014-10-30       Impact factor: 3.913

7.  Automating standard alcohol use assessment instruments via interactive voice response technology.

Authors:  James C Mundt; Michael J Bohn; Monica King; Michael T Hartley
Journal:  Alcohol Clin Exp Res       Date:  2002-02       Impact factor: 3.455

8.  The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.

Authors:  Lynn E Sullivan; Brent A Moore; Patrick G O'Connor; Declan T Barry; Marek C Chawarski; Richard S Schottenfeld; David A Fiellin
Journal:  Am J Addict       Date:  2010 Jan-Feb

9.  Alcohol treatment research assessment exposure subject reactivity effects: part II. Treatment engagement and involvement.

Authors:  Stephen A Maisto; Patrick R Clifford; Christine M Davis
Journal:  J Stud Alcohol Drugs       Date:  2007-07       Impact factor: 2.582

10.  Web-based cognitive behavioral relapse prevention program with tailored feedback for people with methamphetamine and other drug use problems: protocol for a multicenter randomized controlled trial in Japan.

Authors:  Ayumi Takano; Yuki Miyamoto; Norito Kawakami; Toshihiko Matsumoto; Tomohiro Shinozaki; Takashi Sugimoto
Journal:  BMC Psychiatry       Date:  2016-04-04       Impact factor: 3.630

View more
  2 in total

1.  A randomized clinical trial of the Recovery Line among methadone treatment patients with ongoing illicit drug use.

Authors:  Brent A Moore; Frank D Buono; Daniel P Lloyd; Destiny M B Printz; David A Fiellin; Declan T Barry
Journal:  J Subst Abuse Treat       Date:  2018-11-24

2.  Retrospective Chart Review of Voluntary Admissions to an Inpatient Psychiatric Hospital in New York City: A Demographic Breakdown.

Authors:  Amir Garakani; Brianna M Cerrito; Amy S Aloysi; Jose M Martinez; Frank D Buono
Journal:  Community Ment Health J       Date:  2019-10-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.